Background
Methods
Study selection
Data extraction
Results
Study characteristics
Study variable | Number of studies | |
---|---|---|
Year of Publication | 1970 – 1979 | 7 |
1980 – 1989 | 2 | |
1990 – 1999 | 9 | |
2000 – 2009 | 12 | |
2010—2019 | 23 | |
2020 onwards | 1 | |
Data collection methods | Quantitative -In-person questionnaire -Online questionnaire -Postal questionnaire -In-person and online questionnaires | 47 31 9 6 1 |
Qualitative interviews | 4 | |
Mixed methods | 3 | |
Number of universities included* | 1 | 34 |
2–4 | 3 | |
5–9 | 7 | |
10 + | 3 | |
Not reported | 7 | |
Location of university | England | 24 |
Wales | 4 | |
Scotland | 4 | |
Northern Ireland | 0 | |
Republic of Ireland | 10 | |
Great Britain | 4 | |
UK (Great Britain & Northern Ireland) | 3 | |
Not reported | 5 | |
Degree level | 100% undergraduate | 22 |
Mixed undergraduate and graduate | 8 | |
Nor reported | 24 | |
% of sample female | 30–39 | 3 |
40–49 | 10 | |
50–59 | 12 | |
60–69 | 11 | |
70–79 | 6 | |
80–89 | 2 | |
Not reported | 10 | |
% response rate | 0–19 | 5 |
20–39 | 4 | |
40–59 | 3 | |
60–79 | 11 | |
80–100 | 14 | |
Not applicable | 4 | |
Not reported | 13 |
Study design
Ethical approval and funding source
Drugs assessed
Primary and secondary outcome domains
Author | Location | Design | Method | N | % Undergraduate | Course | Response rate | % female | Mean age (range) | Substances examined | Prevalence | Knowledge/ Attitudes / Motivation | Associated factors | Consequences | Supply |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 uni England | Quantitative—Cross sectional | In-person | 153 | NR | NR | NR | NR | NR | Cannabis, heroin, LSD, amphetamines, other | X | X | ||||
1 uni Scotland | Quantitative—Cross sectional | In-person | 749 (1971) 487 (1972) | 78 73 | Medical students | 95.3 (1971) 80.6 (1972) | NR | NR | Marijuana, hashish, amphetamines, LSD, heroin, cocaine, barbiturates, glue, others | X | X | ||||
1 uni England | Quantitative—Cross sectional | Postal survey | 300 | NR | NR | 33 | NR | NR | Cannabis | X | X | ||||
1 uni England | Quantitative—Cross sectional | Postal survey | 300 | NR | NR | 33 | NR | NR | Cannabis | X | |||||
I uni Ireland | Quantitative—Cross sectional | Postal survey | 444 | 100 | Not limited | 97 | 40 | NR | Marijuana, LSD, ‘barbiturates or amphetamines’, ‘heroin or some hard drug’ | X | X | X | |||
6 unis England | Quantitative—Cross sectional | In-person | 1113 | 100 | Not limited | 65 | NR | 20.9 | Any drugs other than given by your doctor | X | X | ||||
1 uni Ireland | Quantitative—Cross sectional | In-person | 765 | NR | Medical students | 98.6 | 33.3 | NR | Pot, hashish, amphetamines, LSD, heroin, cocaine, barbiturates, glue, others | X | X | ||||
NR | Quantitative—Cross sectional | In-person | 360 | 100 (Med students)NR (non-MS) | Medical and Non-medical (arts, science, agriculture) | 84 (MS) 60 (non-MS) | NR | 20.2 | Cannabis and other drugs | X | X | ||||
4 colleges Scotland | Quantitative—Cross sectional | In-person | 209 | NR | Nursing students | 100 | 89 | NR | Marijuana, analgesics & other drugs | X | X | ||||
13 medical schools (Eng, Scot, Wales) | Quantitative—Cross sectional | Postal survey | 1268 | NR | Medical students | 68 | 48 | 21.4 (17–35) | Cannabis, tranquillisers, cocaine, opiates, hallucinogens, barbiturates, amphetamines, ‘other drugs not taken under medical supervision’ | X | |||||
1 uni England | Quantitative—2 Cross-sectional studies (2 cohort samples collected a year apart) | In-person | 186 | 100 | Medical students | 98.9 | 58.6 | 20.4 | Cannabis, amphetamine, amyl nitrite, LSD, mescaline, ecstasy, magic mushrooms, cocaine, opioids, solvents/gas/glue | X | X | ||||
10 unis (Eng, Scot, Wales) | Quantitative—Cross sectional | In-person | 3075 | 100 | Specified—mixture | Almost 100% | 47 | 20.9 (18–65) | Cannabis, LSD, amphetamines, cocaine/crack, ecstasy, magic mushrooms, amyl nitrate, barbiturates, heroin/morphine/opium, steroids, other drugs | X | X | X | |||
10 unis (Eng, Scot) | Quantitative—Cross sectional | In-person | 3699 | 100 | Specified—mixture | Almost 100% | 48.3 | NR | Cannabis, LSD, amphetamines, cocaine/crack, ecstasy, magic mushrooms, amyl nitrate, barbiturates, heroin/morphine/opium, steroids, other drugs | X | X | ||||
England – unclear no. of unis | Quantitative—Cross sectional | In-person | 186 | NR | Not specified | 62 | 58 | NR (19–25) | Ecstasy | X | X | X | |||
7 universities in GB | Quantitative—Cross sectional | In-person | 785 | 100 | Medical students | Almost 100% | 55.3 | 20 | Cannabis, LSD, amphetamines, cocaine/crack, ecstasy, magic mushrooms, amyl nitrate, barbiturates, heroin/morphine/opium, steroids, other drugs | X | X | X | |||
1 uni England | Quantitative—Cross sectional | Postal survey | 318 | NR | NR | 76 | 44 | NR | Cannabis, LSD, Magic mushroom, Amphetamine, Ecstasy, Solvent/poppers, Cocaine, Sedatives, Crack cocaine, Heroin | X | X | X | |||
1 uni in England | Quantitative—cross-sectional | In-person | 348 | 100 | 9 courses: psychology, law, computer studies, building surveying & housing studies, business studies, government, fashion, marketing, sociology | ‘negligible' | 64.1 | 23.3 | Cannabis, amphetamines, hallucinogens (e.g. LSD), ecstasy, magic mushrooms, nitrites, cocaine, non-Px tranquilisers, heroin and opium derivatives, solvents, others | X | X | ||||
5 unis in Scotland | Quantitative: Cross sectional | In-person | 4065 | 100 | Not limited | 92.2 | 76.7 | 21.6 | Cannabis, amphetamines, cocaine, LSD, ecstasy, heroin | X | X | ||||
1 uni in England | Quantitative: Cross sectional | In-person | 194 | 100 | Medical students | 94.6 | 67 | 18.8 (17–39) | Cannabis, LSD, amphetamines, cocaine/crack, ecstasy, magic mushrooms, amyl nitrate, barbiturates, heroin/morphine/opium, steroids, other drugs | X | X | ||||
1 uni in England | Quantitative: Cross sectional | In-person | 136 | 100 | Medical students | 80.5 | 66.2 | NR | Cannabis, amphetamines, LSD, ecstasy, amyl/butyl nitrate, magic mushrooms | X | |||||
Not reported | Quantitative: cross-sectional | In-person | 200 | 100 | Dental students | 75.8 | NR | NR | Cannabis, amphetamines, amyl nitrate, ecstasy, magic mushrooms, LSD, cocaine, inhalants | X | |||||
1 uni in England | Quantitative: longitudinal | In-person | 122 (1995), 114 (1998) | 100 | Medical students | 80.3% (1995) 79.7 (1998) | 65.6% (1995) 66.7% (1998) | NR | Cannabis, LSD, amphetamines, cocaine/crack, ecstasy, magic mushrooms, amyl nitrate, barbiturates, heroin/morphine/opium, steroids, other drugs | X | X | ||||
1 uni in England | Quantitative: longitudinal | In-person | 380 | 100 | Not limited | 63 | 54.2 | NR (19–53) | Amphetamine, cannabis, LSD, ecstasy | X | X | ||||
1 uni in England | Quantitative: longitudinal | In-person | 47 (2nd yr 1995) 53 (final yr 1998) | 100 | Dental students | 71.2% (1995) 80.3% (1998) | 66% (1995) 49.1% (1998) | NR | Cannabis, LSD, amphetamines, cocaine/crack, ecstasy, magic mushrooms, amyl nitrate, barbiturates, heroin/morphine/opium, steroids, other drugs | X | X | ||||
1 uni in England | Quantitative: Cross sectional | In-person | 254 | 100 | Psychology | 99.2 | 78.7% | 22.3 (F) 21.5 (M) | Cannabis, amphetamine, cocaine, LSD, magic mushrooms, opiates, amyl nitrate, other | X | X | ||||
2 unis in England | Mixed methods: cross-sectional with results informing qualitative | In-person | 176 | NR | Science | N/A | 43.4% | 43.5% | Cannabis and ‘other illicit drugs’ | X | X | ||||
1 UK University | Quantitative—Cross sectional | In-person | 346 | NR | Dental (n = 218) Law (n = 128) students | 78.1 | 54% dental, 59% law | 21.4 dental, 20.4 law | Cannabis, ecstasy, amphetamines, ‘other class A drugs’, ‘other class B and class C drugs’ | X | X | ||||
1 uni Ireland | Quantitative -longitudinal | In-person | 1824 | NR | Medical students | 98.6 (1973) 95.6 (1990) 94.2 (2002) | 33.3 (1973) 51.9 (1990) 59% (2002) | NR | ‘Drugs for other than medical reasons’ | X | X | ||||
> 1 uni England | Qualitative-structured interviews | In-person | 176 | NR | NR | N/A | 43 | 22 | Cannabis | X | |||||
1 uni England | Quantitative-prospective cohort | Online survey | 827 | NR | not limited | 6 | 68 | NR | Cannabis, opiates, amphetamines, crack, cocaine, benzodiazepines, solvents, other | X | X | ||||
> 1 uni England | Quantitative—Cross sectional | In-person | 143 | 100 | Not specified | NR | 58.9 | 18–24 | Cannabis | X | |||||
2 unis England | Quantitative—Cross sectional | In-person | 360 | 90 | Not limited | 65 | 70 | 21.1 (M) 24.3 (F) | Magic mushrooms, ecstasy, LSD, amphetamines, cannabis, tranquilizers, cocaine, heroin, solvents, injected drugs (any type) | X | |||||
1 English uni | Quantitative—Cross sectional | In-person | 265 | 100 | Dental students | 69 | Not reported | NR | Cannabis, amphetamines, amyl nitrate, ecstasy, magic mushrooms, LSD, cocaine, inhalants, steroids | X | X | ||||
1 uni Ireland | Quantitative—Cross sectional | In-person | 181 | NR | Not specified | 91.4 | 75.9 | NR | Cannabis, cocaine, ecstasy, heroin, crystal meth, drugs by injection | X | |||||
2 unis England | Quantitative—Cross sectional | Secondary data analysis | 159 | NR | NR | NR | 49.7 | 21.6 | Ecstasy, amphetamine, cannabis, cocaine | X | |||||
1 uni Ireland | Quantitative—Cross sectional | In-person | 1049 | NR | Not limited | NR | 82 | 21.2 (17–54) | Cannabis, ecstasy, cocaine, LSD, magic mushrooms, heroin | X | X | ||||
1 uni Ireland | Quantitative—Cross sectional | In-person | 760 | NR | NR | 76 | 48 | 22.2 (17–63) | Tranquillisers ± prescription, amphetamine, LSD, cocaine, heroin, ecstasy, drugs by injection, solvents, magic mushrooms, cannabis | X | |||||
1 uni Ireland | Mixed methods—cross-sectional with results informing semi-structured interviews | In-person | 1030 (survey) 59 (interview) | NR | Teacher education and nursing/midwifery | 71 | 54.6 | NR | Cannabis | X | X | X | |||
1 uni UK | Quantitative—Cross sectional | In-person | 473 | 100 | Social Sciences | NR | NR | NR | Cannabis | X | X | ||||
South Wales | Quantitative—Cross sectional | Online survey | 2181 | 100 | Not limited | 33 | 59 | NR | Cannabis, ecstasy, LSD, magic mushrooms, amphetamine, cocaine, ketamine, heroin, crack, methamphetamine, mephedrone, GBL/GHB, Spice, BZP | X | X | ||||
7 unis England, Wales, NI | Quantitative—Cross sectional | In-person | 3706 | NR | Random selection | 80 | 77.9 | 24.9 | ‘Illicit substance’ (includes ecstasy, marijuana, cocaine, heroin, crack, LSD, amphetamines) | X | X | ||||
1 uni Scotland | Quantitative—Cross sectional | Online survey | 1189 | 84 | Not limited | 15 | 68 | NR | Ecstasy, cannabis, cocaine, Ketamine, magic mushroom, LSD, benzodiazepines, amyl nitrate, heroin, amphetamines, crack, methamphetamine, GHB, steroids, 2CB, mephedrone, prescribed medication, NPS, other | X | |||||
1 uni NR | Qualitative—semi-structured interviews | N/A | 30 | 100 | including but not limited to: sociology, business studies and geology | N/A | NR | NR | Cocaine, ecstasy, cannabis, Ketamine, diazepam, mushrooms, mephedrone | X | |||||
1 uni NR | Quantitative—Cross sectional | Online survey | 3683 | NR | not limited | 11.5 | 68.1 | NR | Not fully reported but includes cannabis, ecstasy, cocaine, amyl nitrate, nitrous oxide, DMT, solvents, injecting drug use | X | |||||
1 uni England | Quantitative—Cross sectional | Paper – drop off | 410 | 41.4 | Graduate entry (GE) and undergraduate medical students | 49.1 | GE 56.3 UG 68.8 | GE: 22–26 UG: 18–21 | ‘Drug use’ | X | |||||
7 unis in Wales | Quantitative—Cross sectional | Online survey | 7855 | NR | Not limited | 7.8 | 62.3 | NR | Cannabis, ecstasy, LSD, magic mushrooms, amphetamine, methamphetamine, cocaine powder, crack cocaine, heroin, and tranquilizers | X | |||||
1 uni in England | Mixed methods—cross sectional with quotes from participants | In-person and online | 512 | 91 | Social sciences (sociology, psychology, criminology, politics, international relations) | 41.2 | 62 | NR | Amphetamine, amyl nitrate, cannabis, cocaine, ecstasy, ketamine, LSD, heroin, methadone, crack, methamphetamine, modafinil, Adderall, Ritalin, dexedrine, ephedrine, BZP, khat, mephedrone, Spice, GBL/GHB, other new psychoactive Substances | X | X | X | |||
1 uni in England | Quantitative—Cross sectional | In-person | 1242 | NR | Medical and law students | 78.8 | 51.6 | NR | Amphetamines, anabolic steroids, benzodiazepines or Z-drugs, cannabis, cathinones, cocaine, ecstasy, GBL/GHB, ketamine, LSD, mushrooms, nitrous oxide, opioids, piperazines, synthetic cannabinoids | X | X | ||||
7 unis in Wales | Quantitative—Cross sectional | Online survey | 7855 | NR | All students | 7.8 | 62.3 | NR | Cannabis, ecstasy, LSD, magic mushrooms, amphetamine, methamphetamine, cocaine powder, crack cocaine, heroin, and tranquilizers | X | X | ||||
1 uni in Ireland | Quantitative—Cross sectional | Online survey | 2267 | 90.2 | Not limited | 20.1 | 51.7 | NR | Amphetamine, cocaine, ecstasy/MDMA, ‘head shop products’, heroin, LSD, magic mushrooms, solvents, tranquilisers, drugs by injection | X | |||||
7 unis in Wales | Quantitative—Cross sectional | Online survey | 1877 | NR | NR | NR | NR | NR | Cannabis, ecstasy, LSD, magic mushrooms, amphetamine, methamphetamine, cocaine powder, crack cocaine, heroin, and tranquilizers | X | |||||
1 uni in England | Qualitative—semi-structured interviews | NA | 30 | 100 | Not limited | NA | 30 | NR (18–37) | Cocaine, ecstasy, cannabis, Ketamine, diazepam, mushrooms, mephedrone | X | |||||
Various unis in Ireland | Quantitative—Cross sectional | Online survey | 5672 | 95.1 | Not limited | NR | 48.7 | 21.6 | ‘Non-prescribed/recreational’ | X | X | ||||
1 uni in Ireland | Qualitative—free-text survey | NA | 161 | 59.6 | Medical students | NA | 54.6 | 24.8 (22–42) | ‘Drugs’—not specified | X |
Prevalence or patterns of drug use
Factors associated with drug use
Author | Year | Location | Study design | N | Number of unis | Demographics | Course/ Year of study | Personality or mental health | Attitudes/ health awareness | Normative beliefs | Tobacco or alcohol use | Academic performance | Religious beliefs |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ashton [43] | 1995 | England | Cross-sectional | 186 | 1 | X | |||||||
Barber [86] | 2006 | Not reported | Cross-sectional | 346 | 1 | X | |||||||
Boland [87] | 2006 | Ireland | Longitudinal | 1824 | 1 | X | |||||||
Bogowicz [44] | 2018 | England | Cross-sectional | 1242 | 1 | X | X | X | X | ||||
Butler [85] | 2004 | England | Cross-sectional | 254 | 1 | X | |||||||
Conner [65] | 1998 | England | Cross-sectional | 186 | Not reported | X | X | ||||||
Deasy [93] | 2014 | Ireland | Mixed methods: cross-sectional & semi-structured interviews | 1030 (survey) | 1 | X | |||||||
Einstein [77] | 1975 | Not reported | Cross-sectional | 300 | 1 | X | |||||||
El Ansari [15] | 2015 | England, Wales and Northern Ireland | Cross-sectional | 3706 | 7 | X | X | X | X | X | X | ||
Engs [80] | 1987 | Scotland | Cross-sectional | 209 | 3 | X | |||||||
Engs [82] | 1999 | Scotland | Cross-sectional | 4065 | Not reported | X | X | ||||||
Golding [45] | 1987 | Not reported | Cross-sectional | 360 | 1 | X | X | ||||||
Herity [79] | 1977 | Ireland | Cross-sectional | 765 | 1 | X | X | ||||||
Hindmarch [75] | 1970 | Not reported | Cross-sectional | 153 | 1 | X | X | X | |||||
Holloway [97] | 2018 | Wales | Cross-sectional | 7855 | 7 | X | X | ||||||
McKay [76] | 1973 | Scotland | Cross-sectional | 1236 | 1 | X | X | ||||||
Murphy [99] | 2019 | Ireland | Cross-sectional | 5672 | 31 | X | X | ||||||
Newbury-Birch [48] | 2000 | England | Cross-sectional | 194 | 1 | X | X | ||||||
Newbury-Birch [47] | 2001 | England | Longitudinal | 236 | 1 | X | X | X | |||||
Newbury-Birch [46] | 2002 | England | Longitudinal | 100 | 1 | X | X | ||||||
Parfrey [33] | 1975 | Ireland | Cross-sectional | 444 | 1 | X | |||||||
Roberts [89] | 2010 | England | Cross-sectional | 360 | 2 | X | |||||||
Somekh [78] | 1976 | England | Cross-sectional | 1113 | 6 | X | X | ||||||
Underwood [90] | 2010 | England | Cross-sectional | 265 | 1 | X | |||||||
Vivancos [101] | 2009 | England | Cross-sectional | 827 | 1 | X | |||||||
Webb [49] | 1996 | England, Scotland, Wales | Cross-sectional | 3075 | 10 | X | |||||||
Webb [51] | 1997 | England, Scotland | Cross-sectional | 3699 | 10 | X | |||||||
Webb [50] | 1998 | Not reported | Cross-sectional | 785 | 7 | X | X |